00966112179000
Request Service

About Us

Clinlia > About Us

Who we are

The Future of CLINICAL TRIALS Begins Here

CLINLIA is a proud Saudi clinical research consultancy with extensive experience in providing research support and management services across a broad range of therapeutic areas. We are aligned with Saudi Arabia’s Vision 2030, aiming to advance clinical research and innovation, and position the Kingdom prominently on the global clinical trials map. CLINLIA, driven by limitless ambition, was established in 2021.

80 %

HOSPITALS AND HEALTHCARE PROVIDERS

70 %

PHARMACEUTICAL COMPANIES

60 %

MEDICAL RESEARCH INSTITUTIONS

Watch Video

Our approach ensures that the solutions we provide uphold the values of effectiveness, efficiency, relevance, and adaptability.

SITE MANAGEMENT SERVICES
Dedicated compliance support and regular monitoring ensure adherence to regulatory requirements and effective study management.
TAILORED TRAINING PROGRAMS
Uphold the spirit of innovation and creativity in shaping a solution that can be accepted by the wider community.
CLINICAL TRIAL UNIT ESTABLISHMENT
Developing tailored SOPs and protocols, along with comprehensive staff training and establishing necessary infrastructure, ensures well-prepared and effectively managed CTU operations.

.

.

.

.

check it out

How it Works

CLINICAL TRIALS MANAGEMENT

We provide full oversight of clinical trials from planning to execution, ensuring regulatory compliance, patient safety, and timely delivery of results.
01

BUILDING STRATEGIC PARTNERSHIPS

We collaborate with hospitals, pharmaceutical companies, and research institutions to create strong, value-driven partnerships that support long-term success.
02

EXPERTISE IN SITE MANAGEMENT

Our experienced team ensures smooth site operations including activation, monitoring, and quality assurance to keep studies on track and efficient.
03

DRIVING DATA TRANSFORMATION

We leverage real-time data and advanced analytics to turn raw information into actionable insights that enhance research quality and decision making.
04

ACCESS TO LEADING EXPERTS AND INDUSTRY LEADERS

Clients benefit from our network of top-tier professionals, gaining strategic guidance and deep domain knowledge across every stage of research.
05

CLINICAL TRIALS

2021

Our Beginning

CLINLIA was established as a 100% Saudi owned CRO and consultancy. Launched with a vision aligned to Saudi Arabia’s Vision 2030, aiming to advance the Kingdom’s presence in the global clinical trials landscape.

2022

Operational Readiness

Developed tailored Standard Operating Procedures (SOPs) and infrastructure for Clinical Trial Units (CTUs). Began offering consultations and support services across various therapeutic areas. Formed early strategic partnerships with healthcare providers and academic entities.

2023

Workforce Localization & Quality Compliance

Launched custom training programs to build local capabilities in clinical research. Expanded internal staff through a focus on Saudi expertise development. Adopted Good Clinical Practice (GCP) and Research Ethics compliance models across operations.

2024

Innovation and Technology Integration

Implemented real-time data systems and real-world evidence (RWE) analysis tools. Enhanced operational efficiency with data-driven decision-making tools. Strengthened site management and CTU oversight through digital transformation.

2025

Portfolio Expansion & National Leadership

Launched Pharmacoeconomic Services as a new vertical. Positioned CLINLIA as a regional leader in integrating clinical, economic, and policy-driven research solutions. Expanded partnerships with pharmaceutical companies, hospitals, and research institutions, reinforcing its role in shaping future healthcare strategy.